Heron Therapeutics Inc (NASDAQ:HRTX)

29.65
Delayed Data
As of Jun 18
 -0.30 / -1.00%
Today’s Change
12.70
Today|||52-Week Range
35.40
+63.81%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close29.95
Today’s open29.65
Day’s range29.40 - 30.25
Volume1,252,915
Average volume (3 months)1,218,254
Market cap$2.3B
Data as of 4:00pm ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)+20.05%
Earnings growth (this year)+32.29%
Earnings growth (next 5 years)+18.90%
Revenue growth (last year)+2,305.55%
P/E ratioNM
Price/Sales31.79
Price/Book15.99

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...-0.79-18.37%
ACORAcorda Therapeutics ...-0.45-1.44%
ATNXAthenex Inc+0.37+1.98%
BYSIBeyondspring Inc0.000.00%
Data as of 4:00pm ET, 06/18/2018

Financials

Next reporting dateAugust 6, 2018
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$30.8M
Annual profit (last year)-$197.5M
Net profit margin-641.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President &
Director
Robert H. Rosen
Corporate headquarters
San Diego, California

Forecasts